|
Entity 1
|
Relationship
|
Entity 2
|
Article
|
Frequency
|
Score
|
| hyperplasia | leading-to | restenosis | Reocclusion/restenosis after coronary artery bypass surgery, percutaneous transluminal coronary angioplasty and thrombolysis. | 6 | 38.2084 |
| neointima | cause | restenosis | [Invasive cardiology--focus on restenosis. Part I] | 2 | 34.8298 |
| myocardial infarction | not-associated-with | restenosis | Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty--a report from the M-HEART Group. | 2 | 34.3248 |
| restenosis | associated-with | thrombosis | Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis. | 1 | 34.191 |
| atherosclerosis | analogous | restenosis | Heparin rapidly and selectively regulates protein tyrosine phosphorylation in vascular smooth muscle cells. | 2 | 33.3837 |
| lesions | prone | restenosis | Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. | 1 | 31.1372 |
| stroke | associated-with | restenosis | Long-term follow-up and clinical outcome of carotid restenosis. | 1 | 30.7012 |
| fatty acids | not-associated-with | restenosis | Lipids and fatty acids and their relationship to restenosis. | 1 | 30.7012 |
| ischemia | associated-with | restenosis | Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. | 1 | 30.7012 |
| restenosis | included | diabetes | Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization. | 2 | 30.4205 |
| restenosis | cause | ischemia | Increased thrombin activity correlates with increased ischemic event rate after percutaneous transluminal coronary angioplasty: lack of efficacy of locally delivered urokinase. | 1 | 29.7013 |
| restenosis | cause | angina | Incidence and risk factors predictive of unstable angina resulting from restenosis after percutaneous angioplasty of saphenous vein grafts. | 1 | 29.7013 |
| g aspirin | developed | restenosis | The Frankfurt experience in restenosis after coronary angioplasty. | 1 | 29.5212 |
| restenosis | followed | anastomosis | Traumatic tracheobronchial stricture treated with the Eder-Puestow dilator. | 1 | 29.5174 |
| restenosis | include | diabetes mellitus | [Clinical, angiographic, and procedure factors predicting coronary restenosis after stent implantation: synthesis of the evidence] | 1 | 29.4205 |
| restenosis | occurred-in | lesions | Favourable results of treatment of narrowed saphenous vein grafts with Palmaz-Schatz stent implantation. | 1 | 28.7744 |
| lesion | predictors | restenosis | Candidate genetic markers and the risk of restenosis after coronary angioplasty. | 1 | 28.7498 |
| fibrosis | lead-to | restenosis | Photodynamic therapy inhibits the injury-induced fibrotic response of vascular smooth muscle cells. | 1 | 28.3976 |
| restenosis | leading-to | ischaemia | Longchain n-3 polyunsaturated fatty acids and blood vessel function. | 1 | 28.3976 |
| percent diameter stenosis | predictors | restenosis | Short-term outcome of stent implantation in saphenous vein grafts: predictors of distal embolization and restenosis. | 1 | 28.2425 |
| hyperhomocysteinemia | factor | restenosis | Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction? | 1 | 27.5338 |
| diabetes mellitus | higher | restenosis | Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty. | 1 | 27.5221 |
| fluvastatin | influence | restenosis | [Clinical study of the month. The LIPS study: fluvastatin for prevention of cardiac events following percutaneous coronary angioplasty] | 1 | 27.3172 |
| restenosis | based-on | percent diameter stenosis | Alterations in reference vessel diameter following intracoronary stent implantation: important consequences for restenosis based on percent diameter stenosis. | 1 | 27.1903 |
| hyperemia | lower | restenosis | Impaired forearm reactive hyperemia is related to late restenosis after coronary stenting. | 1 | 27.1612 |
| restenosis | lower | pravastatin | Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial). | 1 | 27.1612 |
| diabetes | correlated | restenosis | Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM). | 1 | 26.7838 |
| hyperproliferation | feature | restenosis | Heparin inhibits phosphorylation and autonomous activity of Ca(2+)/calmodulin-dependent protein kinase II in vascular smooth muscle cells. | 1 | 26.3613 |
| stress | characteristic | restenosis | Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery. | 1 | 25.9558 |
| restenosis | target | lesion | Standardized angiographically guided over-dilatation of stents using high pressure technique optimize results without increasing risks. | 1 | 25.7362 |
| serum cholesterol | factors | restenosis | Effects of stent design and serum cholesterol level on the restenosis rate in atherosclerotic rabbits. | 1 | 25.5339 |
| hyperinsulinemia | predictor | restenosis | Hyperinsulinemia as a risk factor for restenosis after coronary balloon angioplasty. | 1 | 25.4427 |
| triglyceride | unrelated | restenosis | Restenosis after transluminal coronary angioplasty: a risk factor analysis. | 1 | 24.8712 |
| cardiovascular diseases | prevention | restenosis | Genetic therapy. | 1 | 23.4849 |
| probucol | inhibits | restenosis | Dietary and pharmacological antioxidants in atherosclerosis. | 3 | 16.6355 |
| angina | resulting-from | restenosis | Incidence and risk factors predictive of unstable angina resulting from restenosis after percutaneous angioplasty of saphenous vein grafts. | 1 | 14.1118 |
| pravastatin | reduces | restenosis | Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial). | 1 | 12.611 |
| sarpogrelate | reduces | restenosis | Sarpogrelate treatment reduces restenosis after coronary stenting. | 1 | 12.3968 |
| stenosis | defined | restenosis | Restenosis after a first percutaneous transluminal renal angioplasty. | 1 | 12.39 |
| lovastatin | prevented | restenosis | Prevention of restenosis by lovastatin after successful coronary angioplasty. | 2 | 12.3062 |
| heparin | reduce | restenosis | Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. A quantitative angiographic and histopathological study. | 1 | 11.8527 |
| hydrocortisone | reduces | restenosis | Hydrocortisone reduces restenosis after stenting of small coronary arteries. | 1 | 11.3411 |
| quinapril | prevents | restenosis | Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele. | 1 | 10.9114 |
| restenosis | defined-as | diameter stenosis | Preventive effects of an antiallergic drug, pemirolast potassium, on restenosis after percutaneous transluminal coronary angioplasty. | 5 | 10.6021 |
| colchicine | not-prevent | restenosis | Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty. | 1 | 10.5779 |
| restenosis | using | sirolimus | Drug-eluting stent: the emerging technique for the prevention of restenosis. | 1 | 9.7862 |
| restenosis | using | rat | Inhibition of ribonucleotide reductase reduces neointimal formation following balloon injury. | 1 | 9.7862 |
| angiogenesis | inhibit | restenosis | Decreased adventitial neovascularization after intracoronary irradiation in swine: a time course study. | 1 | 9.7851 |
| restenosis | requiring | target lesion | Incomplete expansion of Palmaz-Schatz stents despite high-pressure implantation technique: impact on target lesion revascularization. | 2 | 9.3304 |
| carvedilol | reduces | restenosis | Comparison between a sustained administration of carvedilol versus atenolol to reduce restenosis after coronary stenting. | 1 | 9.1577 |
